Biomea's diabetes drug shows promise, may work for those responding to GLP-1 – Reuters

Written by

admin

in

  1. Biomea’s diabetes drug shows promise, may work for those responding to GLP-1  Reuters
  2. Icovamenib shows sustained benefits for hard-to-treat diabetes patients  Investing.com
  3. Biomea Fusion Announces Positive Phase II Study Results  TipRanks
  4. Biomea Fusion Reports Positive 52-Week Results from Phase II COVALENT-111 Study of Icovamenib in Type 2 Diabetes Patients  Quiver Quantitative
  5. Biomea Fusion reports 52-week results from Phase II diabetes trial  Investing.com

Continue Reading

More posts